BCAB — Bioatla Cashflow Statement
0.000.00%
HealthcareSpeculativeSmall CapNeutral
- $145.16m
- -$32.96m
- $0.25m
- 28
- 33
- 55
- 32
Annual cashflow statement for Bioatla, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -29 | -29.9 | -35.9 | -95.4 |
Depreciation | ||||
Non-Cash Items | 3.52 | -4.48 | 1.87 | 24.4 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | -10.7 | 23.8 | -3.36 | 7.42 |
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Payable / Accrued Expenses | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | -35.3 | -9.64 | -36.3 | -62.2 |
Capital Expenditures | -0.988 | -1.51 | -0.59 | -0.924 |
Purchase of Fixed Assets | ||||
Cash from Investing Activities | -0.988 | -1.51 | -0.59 | -0.924 |
Financing Cash Flow Items | 0.019 | -0.005 | 200 | -1.91 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 5.02 | 4 | 272 | 69.5 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | -31.3 | -7.16 | 235 | 6.37 |